18 December 2020 Letter from the CEO: Great progress in 2020 – we are ready for 2021! Download Presentation Webcast Workbook
16 December 2020Regulatory Scandion Oncology A/S – Flagging message Download Presentation Webcast Workbook
15 December 2020Regulatory Scandion Oncology: Supplement to previously published press release regarding the outcome of Scandion Oncology’s rights issue Download Presentation Webcast Workbook
15 December 2020Regulatory SCANDION ONCOLOGY ANNOUNCES OUTCOME IN THE RIGHTS ISSUE Download Presentation Webcast Workbook
24 November 2020Regulatory Scandion Oncology publishes prospectus relating to the rights issue and announces the intention of changing listing venue to Nasdaq First North Growth Market Sweden Download Presentation Webcast Workbook
19 November 2020Regulatory Scandion Oncology – Interim Report Q3 2020 Download Presentation Webcast Workbook
17 November 2020Regulatory Correction of previously published press release regarding Scandion Oncology’s rights issue (trading in BTAs) Download Presentation Webcast Workbook
16 November 2020Regulatory The Board of Directors of Scandion Oncology has resolved on a fully guaranteed rights issue of approximately SEK 236 million Download Presentation Webcast Workbook
13 November 2020 Correction: Scandion Oncology – Minutes of extraordinary general meeting Download Presentation Webcast Workbook
13 November 2020Regulatory Scandion Oncology – Minutes of extraordinary general meeting Download Presentation Webcast Workbook
28 October 2020Regulatory Scandion Oncology: Notice to convene Extraordinary General Meeting in Scandion Oncology A/S Download Presentation Webcast Workbook
28 October 2020Regulatory Scandion Oncology A/S initiates its second clinical study with SCO-101 Download Presentation Webcast Workbook